Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 6368

But one idea that hasn’t gotten enough attention from the AI community is how the brain creates itself, argues Peter Robin Hiesinger, Professor of Neurobiology at the Free University of Berlin (Freie Universität Berlin).

In his book The Self-Assembling Brain, Hiesinger suggests that instead of looking at the brain from an endpoint perspective, we should study how information encoded in the genome is transformed to become the brain as we grow. This line of study might help discover new ideas and directions of research for the AI community.

The Self-Assembling Brain is organized as a series of seminar presentations interspersed with discussions between a robotics engineer, a neuroscientist, a geneticist, and an AI researcher. The thought-provoking conversations help to understand the views and the holes of each field on topics related to the mind, the brain, intelligence, and AI.

Read more | >

New gene therapy in trials for Danon disease.

“The only available treatment option for Danon disease is a heart transplant. Currently, there are no specific therapies available for the treatment of Danon disease.”

The U.S. Food and Drug Administration (FDA) lifted the clinical hold it placed on Rocket Pharmaceuticals’ experimental gene therapy for Danon disease. Patient enrollment in the Phase I study will resume, the company announced this morning.

New Jersey-based Rocket Pharmaceuticals said it intends to resume the Phase I program as quickly as possible. Dosing of patients in the pediatric cohort that was receiving the lowest-level of the medication will resume in the third quarter.

Continue reading “Rocket Relaunches Gene Therapy Program as FDA Lifts Clinical Hold” | >

Summary: In order to understand life’s full range of forms, new theoretical frameworks must be developed, researchers say.

Source: Santa Fe Institute.

The history of life on Earth has often been likened to a four-billion-year-old torch relay. One flame, lit at the beginning of the chain, continues to pass on life in the same form all the way down. But what if life is better understood on the analogy of the eye, a convergent organ that evolved from independent origins? What if life evolved not just once, but multiple times independently?

Read more | >

In order to feed a projected 9 billion people by 2,050 farmers need to grow 50% more food on a limited amount of arable land. As a result, plant scientists are in a race against time to engineer crops with higher yields by improving photosynthesis.

Blue-green algae (cyanobacteria) are known to photosynthesize more efficiently than most crops, so researchers are working to put elements from cyanobacteria into crop plants.

A new study describes a significant step towards achieving that goal. “Absence of Carbonic Anhydrase in Chloroplasts Affects C3 Plant Development but Not Photosynthesis,” published on August 11 2021, in the Proceedings of the National Academy of Sciences.

Read more | >

Summary: Study reveals how the brain analyzes different types of speech which may be linked to how we comprehend sentences and calculate mathematical equations.

Source: SfN

Separate math and language networks segregate naturally when listeners pay attention to one type over the other, according to research recently published in Journal of Neuroscience.

Read more | >

Intelligent systems engineer, STEM advocate, hip-hop artist — ashley llorens, VP, distinguished scientist, managing director microsoft research, microsoft.

Ashley Llorens (https://www.microsoft.com/en-us/research/people/allorens/) is Vice President, Distinguished Scientist & Managing Director, at Microsoft Research Outreach, where he leads a global team to amplify the impact of research at Microsoft and to advance the cause of science and technology research around the world. His team is responsible for driving strategy and execution for Microsoft Research engagement with the rest of Microsoft and with the broader science and technology community, and they invest in high-impact collaborative research projects on behalf of the company, create pipelines for diverse, world-class talent, and generate awareness of the current and envisioned future impact of science and technology research.

Prior to joining Microsoft, Mr. Llorens served as the founding chief of the Intelligent Systems Center at the Johns Hopkins Applied Physics Laboratory (APL), where he directed research and development in artificial intelligence (AI), robotics and neuroscience and created APL’s first enterprise-wide AI strategy and technology roadmap. During his two decades at APL, Mr. Llorens led interdisciplinary teams in developing novel AI technologies from concept to real-world application with a focus on autonomous systems. His background is in machine learning and signal processing and current research interests include reinforcement learning for real-world systems, machine decision-making under uncertainty, human-machine teaming, and practical AI safety.

Continue reading “Ashley Llorens — VP, Distinguished Scientist & Managing Director, Microsoft Research Outreach” | >

By Susan Ip-Jewell## **Space Medicine, Health and MedTech Innovations, a lecture by Susan Ip-Jewell**

In the frame of the new Space Renaissance Academy Webinar Series programme, chaired by the optimum Sabine Heinz, a quite interesting and rich lecture was given yesterday by Dr. Susan Ip Jewell.

Susan is CEO and founder of Mars Moon Astronautic Academy Research Science (MMAARS), one of the SRI VicePresidents and a pasionate space activist. And she’s Commander of Analog Training missions on Moon and Mars simulated surface.

In her lecture, she gives us a wide overlook on many aspects of human health in space, the edge of the space medicine, the innovative techniques using incremental technologies, developing systems integrating robotic, artificial intelligence, remote telemedicine, avatars and drones.

Continue reading “Space Medicine, Health and MedTech Innovations, a lecture” | >